Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)
- Conditions
- SARS-CoV-2 Infection
- Registration Number
- NCT05687877
- Lead Sponsor
- AstraZeneca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria:<br><br> - For treatment of symptomatic disease caused by SARS-CoV-2 infection; Patients with<br> risk factors for severe SARS-CoV-2 infection who do not require supplemental oxygen.<br><br> - For prevention of symptomatic disease caused by SARS-CoV-2 infection; Individuals<br> for whom SARS-CoV-2 vaccination is not recommended OR those who are considered to<br> have an inadequate response to a COVID-19 vaccine due to immunodeficiencies AND who<br> is not close contacts such as family members or other people living in the same<br> dwelling as patients infected with SARS-CoV-2.<br><br>Exclusion Criteria:<br><br> - None
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of ADRs
- Secondary Outcome Measures
Name Time Method